[用ACT监测心脏手术中的肝素化:波尔多大学医院中心即时护理测试的认可]。

IF 0.4 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Annales de biologie clinique Pub Date : 2023-05-16 DOI:10.1684/abc.2023.1794
Valentin Landrieu, Marie Christine Beauvieux, Thomas Vidal, Christine Mouton, Gladys Castaing-Mouhica, Laurent Dusseau, Eugen Stanciu, Julien Domingorena, David Roux, Julien Catel, Valerie Moreno, Nathalie Berthon, Delphine Bachellerie, Sandy Poisvert, Céline Delassasseigne
{"title":"[用ACT监测心脏手术中的肝素化:波尔多大学医院中心即时护理测试的认可]。","authors":"Valentin Landrieu,&nbsp;Marie Christine Beauvieux,&nbsp;Thomas Vidal,&nbsp;Christine Mouton,&nbsp;Gladys Castaing-Mouhica,&nbsp;Laurent Dusseau,&nbsp;Eugen Stanciu,&nbsp;Julien Domingorena,&nbsp;David Roux,&nbsp;Julien Catel,&nbsp;Valerie Moreno,&nbsp;Nathalie Berthon,&nbsp;Delphine Bachellerie,&nbsp;Sandy Poisvert,&nbsp;Céline Delassasseigne","doi":"10.1684/abc.2023.1794","DOIUrl":null,"url":null,"abstract":"<p><p>ACT (Activated Clotting Time) is a point of care test (POCT) on whole blood, used to monitor the heparinization of patients in the operating room in cardiac surgery (ExtraCorporeal Circulation ECC) and in interventional cardiology (TAVI, AF ablation). The ACT is concerned both by the ISO 22 870 standard and French regulations regarding POCT. We performed an important work at the Bordeaux CHU on its accreditation, by rationalizing and making the park uniform (11 HemochronTM Signature Elite), standardizing the training and the habilitation of operators in medical units, introducing periodic quality controls, centralizing in the laboratory the management of the devices and reagents and by connecting it to the laboratory's computer system (Middleware, SIL et expert softwares). One year after, we have some positive feedbacks with only a few technical problems and with only few remarks raised during internal audits.</p>","PeriodicalId":7892,"journal":{"name":"Annales de biologie clinique","volume":"81 2","pages":"168-180"},"PeriodicalIF":0.4000,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Monitoring of heparinization in cardiac surgery with ACT: accreditation of the point-of-care test in the Bordeaux University Hospital Centre].\",\"authors\":\"Valentin Landrieu,&nbsp;Marie Christine Beauvieux,&nbsp;Thomas Vidal,&nbsp;Christine Mouton,&nbsp;Gladys Castaing-Mouhica,&nbsp;Laurent Dusseau,&nbsp;Eugen Stanciu,&nbsp;Julien Domingorena,&nbsp;David Roux,&nbsp;Julien Catel,&nbsp;Valerie Moreno,&nbsp;Nathalie Berthon,&nbsp;Delphine Bachellerie,&nbsp;Sandy Poisvert,&nbsp;Céline Delassasseigne\",\"doi\":\"10.1684/abc.2023.1794\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>ACT (Activated Clotting Time) is a point of care test (POCT) on whole blood, used to monitor the heparinization of patients in the operating room in cardiac surgery (ExtraCorporeal Circulation ECC) and in interventional cardiology (TAVI, AF ablation). The ACT is concerned both by the ISO 22 870 standard and French regulations regarding POCT. We performed an important work at the Bordeaux CHU on its accreditation, by rationalizing and making the park uniform (11 HemochronTM Signature Elite), standardizing the training and the habilitation of operators in medical units, introducing periodic quality controls, centralizing in the laboratory the management of the devices and reagents and by connecting it to the laboratory's computer system (Middleware, SIL et expert softwares). One year after, we have some positive feedbacks with only a few technical problems and with only few remarks raised during internal audits.</p>\",\"PeriodicalId\":7892,\"journal\":{\"name\":\"Annales de biologie clinique\",\"volume\":\"81 2\",\"pages\":\"168-180\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2023-05-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales de biologie clinique\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1684/abc.2023.1794\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales de biologie clinique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1684/abc.2023.1794","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

ACT(活化凝血时间)是一种全血护理点试验(POCT),用于心脏外科手术(体外循环ECC)和介入心脏病学(TAVI, AF消融)中手术室患者的肝素化监测。ACT关注的是ISO 22870标准和法国关于POCT的法规。我们在波尔多CHU进行了一项重要的认证工作,通过合理化和制定园区统一(11 chrontm签名精英),标准化医疗单位操作员的培训和培训,引入定期质量控制,在实验室集中管理设备和试剂,并将其连接到实验室的计算机系统(中间件,SIL等专家软件)。一年后,我们得到了一些积极的反馈,只有一些技术问题,在内部审计中只有很少的评论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Monitoring of heparinization in cardiac surgery with ACT: accreditation of the point-of-care test in the Bordeaux University Hospital Centre].

ACT (Activated Clotting Time) is a point of care test (POCT) on whole blood, used to monitor the heparinization of patients in the operating room in cardiac surgery (ExtraCorporeal Circulation ECC) and in interventional cardiology (TAVI, AF ablation). The ACT is concerned both by the ISO 22 870 standard and French regulations regarding POCT. We performed an important work at the Bordeaux CHU on its accreditation, by rationalizing and making the park uniform (11 HemochronTM Signature Elite), standardizing the training and the habilitation of operators in medical units, introducing periodic quality controls, centralizing in the laboratory the management of the devices and reagents and by connecting it to the laboratory's computer system (Middleware, SIL et expert softwares). One year after, we have some positive feedbacks with only a few technical problems and with only few remarks raised during internal audits.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annales de biologie clinique
Annales de biologie clinique 医学-医学:研究与实验
CiteScore
0.80
自引率
20.00%
发文量
53
审稿时长
6-12 weeks
期刊介绍: Multidisciplinary information with direct relevance to everyday practice Annales de Biologie Clinique, the official journal of the French Society of Clinical Biology (SFBC), supports biologists in areas including continuing education, laboratory accreditation and technique validation. With original articles, abstracts and accounts of everyday practice, the journal provides details of advances in knowledge, techniques and equipment, as well as a forum for discussion open to the entire community.
期刊最新文献
[Atlas of flow cytometry images: lymphoproliferative syndromes - Additional images obtained with DxFlex]. [Use of heparin calibrated anti-Xa assay for apixaban and rivaroxaban measurement in the context of regional telestroke activity]. Importance of the reticulocyte hemoglobin equivalent in the exclusion of latent iron deficiency. [Evaluation of a diagnostic test for heparin-induced thrombocytopenia: validation of a delayed test time]. Association between the Estrogen receptor β rs1256049 polymorphism and prostate cancer risk:a meta-analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1